Natural Selections

Seven wonder drugs that do grow on trees.

Illustration: Bettmann/Corbis

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.


As much as three-quarters of the drugs approved to treat infectious disease and cancer over the past 25 years originated with chemicals or compounds first found in nature. Which means that last acre of rainforest or ocean floor might contain ever more promising cures. A few notable pharmaceuticals that got their start outside the laboratory:

ASPIRIN In the fifth century BC, Hippocrates noted willow bark’s ability to fight fevers and pain. A chemical found in the bark became the key ingredient of aspirin, patented in 1900.

QUININE Indigenous Peruvians used the bark of the cinchona tree to cure fevers. European scientists isolated its antimalarial ingredient in the early 19th century.

LOVASTATIN This chemical, found in the fungus Aspergillus terreus and oyster mushrooms, reduces LDL “bad” cholesterol. In 1987 it became the first FDA-approved statin.

CALANOLIDE A In the late 1980s, a rare tree from Borneo was found to have antiretroviral properties. Still in trials, the resulting drug has shown promise in combating HIV.

TAXOL Tumor-fighting compound derived from the bark of the Pacific yew, introduced as a cancer drug in 1993. It’s since been found in some mushrooms and mycelia.

YONDELIS A cancer drug modeled after an agent discovered in a Caribbean sea squirt. Currently available only in the EU.

PRIALT In 2004, Elan Pharmaceuticals unveiled this drug for treating chronic pain, made from synthetic sea-snail venom. The drug’s logo is a snail shell.

Don’t just click away.

We need your help. We’re halfway through our Summer Membership Drive, and only $35,000 toward our $200,000 goal. But there’s good news: This week only, every donation will be doubled, up to $50,000, thanks to a generous reader.

That’s twice the impact for intrepid reporting that peels back the layers to publish the truth—and the context you need to break it all down. It’s twice the fuel for investigations on voting rights and justice, critical in this midterm election year. And it’s twice the power for exposing the chaos and corruption of a White House trying to control the narrative.

This is a pivotal moment in our nation, with democracy on the line, and we can only do this work because readers like you step up. Every donation, of any amount, makes a difference here. And every donation will be doubled.

We cannot do this work without you. Join the fight. Double your donation to defend democracy.

Don’t just click away.

We need your help. We’re halfway through our Summer Membership Drive, and only $35,000 toward our $200,000 goal. But there’s good news: This week only, every donation will be doubled, up to $50,000, thanks to a generous reader.

That’s twice the impact for intrepid reporting that peels back the layers to publish the truth—and the context you need to break it all down. It’s twice the fuel for investigations on voting rights and justice, critical in this midterm election year. And it’s twice the power for exposing the chaos and corruption of a White House trying to control the narrative.

This is a pivotal moment in our nation, with democracy on the line, and we can only do this work because readers like you step up. Every donation, of any amount, makes a difference here. And every donation will be doubled.

We cannot do this work without you. Join the fight. Double your donation to defend democracy.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

INDEPENDENT. BECAUSE OF YOU.

Mother Jones has no billionaires calling the shots—just readers like you making fearless reporting possible

Donate